data curation, Nusly Andres Montenegro and Sidnee Molina Gutierrez
SGLT2 inhibitorrelated adverse effects, including genital mycotic infections, volume depletion, and rarely ketoacidosis, remain clinically relevant and should be considered when these agents are prescribed as part of combination therapy and importantly, the intrinsic risk of hypoglycemia with combined GLP-1 receptor agonist and SGLT2 inhibitor therapy is low because neither class directly stimulates insulin secretion in a glucose-independent manner and when hypoglycemia occurs, it is more commonly related to concomitant insulin or sulfonylurea use rather than the combination itself [41, 42, 44]
Therefore, our study indicates that in clinical cases of unexplained hemolytic anemia and metabolic acidosis, GSSD should be considered
Maintaining muscle protein synthesis during a caloric deficit is always beneficial, and resistance training has well-established cardiovascular benefits that I write about regularly
"Growth hormone therapy in older adults: risks and benefits." Ann Intern Med
Semaglutide to Tirzepatide Dose Conversion How Dosages Compare Between Semaglutide and Tirzepatide Tirzepatide is typically administered once a week, just like Semaglutide